Contacts
Address
Pakistan, Sindh, Karachi, Plot No.23 Sector No.22, Korangi Industrial Area
Phones of enterprise
management
+92
When placing an order please inform the manager that you've learned the information on Allbiz! Thank you that you buy on Allbiz!
+92
When placing an order please inform the manager that you've learned the information on Allbiz! Thank you that you buy on Allbiz!
Internet
Site:
About enterprise
Aventis pharma (Pakistan), Ltd.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in healthcare, with 6 growth platforms: emerging markets, vaccines, consumer healthcare, diabetes treatments, innovative products and animal health. Through the acquisition of Genzyme, Sanofi has strongly reinforced its footprint in rare diseases.
In stock
Sanofi is a global leader in consumer healthcare.
Since 2008, with targeted acquisitions, Sanofi has been implementing an important strategy of diversifying. Accelerating growth in consumer healthcare also involves regional development hubs in the US, Europe, Asia-Pacific and Latin America.
The...
Group: Pharmaceutical Medicines
In stock
To respond to the needs of the greatest possible number of patients throughout the world, Sanofi has intensified its strategy of diversification on the generics market.
Sanofi continues to strengthen its generic activities. This is particularly visible in Emerging Markets, with the acquisitions...
Group: Pharmaceutical Medicines
In stock
Sanofi's Animal Health activity, represented by Merial, is dedicated to the research, development, manufacture and commercialization of innovative pharmaceutical products and vaccines for animals. Its products are used by veterinarians, stock breeders, poultry producers and pet owners.
The range...
Group: Veterinary medication
In stock
Sanofi is focused on providing answers for patients in a number of pathologies, including in particular the prevention and treatment of thrombosis and cardiovascular diseases.
In thrombosis our leading medicines are:
Plavix® (clopidogrel bisulfate), an antiplatelet agent indicated in the...
Group: Pharmaceutical Medicines
In stock
The 6,000 to 8,000 rare diseases are characterized by a broad diversity of disorders and symptoms.
The patients' quality of life is affected by the lack or loss of autonomy due to the chronic, progressive, degenerative, and frequently life-threatening aspects of the disease.
Our Rare Disease...
Group: Pharmaceutical Medicines
In stock
Sanofi's mission is to create solutions for currently unmet medical needs. Sanofi employ innovative approaches to attack cancer on all fronts and provide medicines adapted to the diverse profiles of patients.
Group: Pharmaceutical Medicines
In stock
Protecting and improving human health worldwide is our primary objective. Sanofi thus provides patients with one of the world's largest ranges of vaccines for the prevention and treatment of diseases.
Sanofi, with its vaccines division Sanofi Pasteur, is a world leader in the field of...
Group: Pharmaceutical Medicines
In stock
Worldwide, 250 million people are currently living with diabetes, and this population will grow to 380 million before 2025. Building upon its century long history in this field, Sanofi is committed to improving global diabetes management through its integrated offering of treatments, medical...
Group: Pharmaceutical Medicines
